Successful treatment of IgG and complement-mediated autoimmune hemolytic anemia with bortezomib and low-dose cyclophosphamide

Am J Hematol. 2011 Mar;86(3):331-2. doi: 10.1002/ajh.21950. Epub 2011 Jan 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Hemolytic, Autoimmune / drug therapy*
  • Anemia, Hemolytic, Autoimmune / etiology
  • Anemia, Hemolytic, Autoimmune / immunology*
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Complement System Proteins / immunology
  • Cyclophosphamide / therapeutic use
  • Female
  • Humans
  • Immunoglobulin G / immunology
  • Middle Aged
  • Pyrazines / therapeutic use

Substances

  • Boronic Acids
  • Immunoglobulin G
  • Pyrazines
  • Bortezomib
  • Cyclophosphamide
  • Complement System Proteins